Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(67%)

Phase Distribution

Ph phase_1
1
33%
Ph phase_2
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (50.0%)
Phase 21 (50.0%)

Trials by Status

terminated267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminatedphase_2

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

NCT05177107
terminatedphase_1

Bacteriophage Therapy in Patients With Urinary Tract Infections

NCT04287478
completed

Bacteriophage Therapy of Difficult-to-treat Infections

NCT05498363

Clinical Trials (3)

Showing 3 of 3 trials
NCT05177107Phase 2

Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

Terminated
NCT04287478Phase 1

Bacteriophage Therapy in Patients With Urinary Tract Infections

Terminated
NCT05498363

Bacteriophage Therapy of Difficult-to-treat Infections

Completed

All 3 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
3